Zejian Zhang

Alteration of Serum IgG Galactosylation as a Potential Biomarker for Diagnosis of Neuroblastoma

Jianxin Gu, K. Dong, Wenjun Qin, 2018, Journal of Cancer.

Serum Linkage-Specific Sialylation Changes Are Potential Biomarkers for Monitoring and Predicting the Recurrence of Papillary Thyroid Cancer Following Thyroidectomy

Mengwei Wu, Xiequn Xu, Zejian Zhang, 2022, Frontiers in Endocrinology.

Quantitative analysis of serum IgG galactosylation assists differential diagnosis of ovarian cancer.

Yuanyuan Ruan, Jianxin Gu, Yifan Qian, 2013, Journal of proteome research.

Discovery of Non-invasive Glycan Biomarkers for Detection and Surveillance of Gastric Cancer

Jianxin Gu, Xuefei Wang, Yihong Sun, 2017, Journal of Cancer.

Discovery of Specific Metastasis-Related N-Glycan Alterations in Epithelial Ovarian Cancer Based on Quantitative Glycomics

Congjian Xu, Jianxin Gu, Jiejie Xu, 2014, PloS one.

Distribution of IgG galactosylation as a promising biomarker for cancer screening in multiple cancer types

Congjian Xu, Lin Guo, R. Lu, 2016, Cell Research.

Providing Bionic Glycome as internal standards by glycan reducing and isotope labeling for reliable and simple quantitation of N-glycome based on MALDI- MS.

Wenjun Qin, Ruihuan Qin, Ran Zhao, 2019, Analytica chimica acta.